Patents Assigned to Abbott Diabetes Care Inc.
  • Publication number: 20220296132
    Abstract: Method and apparatus for optimizing analyte sensor calibration including receiving a current blood glucose measurement, retrieving a time information for an upcoming scheduled calibration event for calibrating an analyte sensor, determining temporal proximity between the current blood glucose measurement and the retrieved time information for the upcoming calibration event, initiating a calibration routine to calibrate the analyte sensor when the determined temporal proximity is within a predetermined time period, and overriding the upcoming scheduled calibration event using the current blood glucose measurement are provided.
    Type: Application
    Filed: June 7, 2022
    Publication date: September 22, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Erwin Satrya Budiman, Wesley Scott Harper, Timothy Christian Dunn
  • Patent number: 11445910
    Abstract: Methods and systems for providing therapy related data management are provided. The subject systems include one or more device components, and at least one memory storage unit and at least one data storage unit associated with such one or more device components. The device components may include one or more of an analyte monitoring system, a fluid delivery device and a remote terminal. The subject methods include use of the subject systems to optimize treatment of a patient.
    Type: Grant
    Filed: July 3, 2017
    Date of Patent: September 20, 2022
    Assignee: Abbott Diabetes Care Inc.
    Inventor: R. Curtis Jennewine
  • Patent number: 11439326
    Abstract: An analyte sensor including an antiglycolytic agent or a precursor thereof and a chelating agent that stabilizes the antiglycolytic agent positioned proximate to the working electrode of the sensor. Also provided are systems and methods of using the electrochemical analyte sensors in analyte monitoring.
    Type: Grant
    Filed: January 21, 2019
    Date of Patent: September 13, 2022
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Tianmei Ouyang, Zenghe Liu, Hyun Cho, Benjamin J. Feldman
  • Publication number: 20220283042
    Abstract: Disclosed herein are methods and systems for conserving energy of a power source of an analyte monitoring device, including entering a power saving mode based on at least one of a temperature level of a power source, a level of power of a power source, or an amount of power needed by at least one component. Also disclosed herein are methods and systems for reducing noise during data transmissions to and from the analyte monitoring device.
    Type: Application
    Filed: October 19, 2021
    Publication date: September 8, 2022
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Saeed Nekoomaram, Martin J. Fennell, Mark Kent Sloan, Lei He, Jeffery Mario Sicurello
  • Patent number: 11432750
    Abstract: In vivo monitoring devices and systems for enzymes and/or analytes including devices having a reactant reservoir are provided.
    Type: Grant
    Filed: March 13, 2017
    Date of Patent: September 6, 2022
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Mark Eshoo, Benjamin Feldman, Tianmei Ouyang, Lam Tran
  • Publication number: 20220273200
    Abstract: On-body analyte sensors may be designed for extended wear to provide ongoing measurement of physiological analyte levels. However, on-body analyte sensors may be susceptible to damage or dislodgment during wear due to routine interactions that occur with one's surroundings. Guard rings may be adapted to protect on-body analyte sensors from such interactions. Guard rings may comprise an annular body comprising an inner perimeter face, an outer perimeter face, a top edge, and a bottom face adapted for contacting a tissue surface. The inner perimeter face is shaped to circumferentially surround a sensor housing of an on-body analyte sensor. At least a portion of the outer perimeter face defines a chamfered surface extending between the top face and the bottom face. Adhesive pads or strips may further be engaged with the guard rings and aid in securing the guard rings to a surface, such as skin.
    Type: Application
    Filed: March 28, 2022
    Publication date: September 1, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Steven T. MITCHELL, Frank David FUJIMOTO, Hyun Brian CHO
  • Publication number: 20220273199
    Abstract: Methods and systems for providing continuous monitoring of analytes using analyte sensors are disclosed. Techniques include a receiving device comprising a communication unit configured to wirelessly communicate with a first and second transmitter unit, processors coupled to the communication unit and a memory coupled to the processors storing instructions which, when executed by the processors receive one or more first data signals from the first transmitter unit; receive, while the first glucose sensor is positioned and the second glucose sensor is positioned, a user input corresponding to a code; receive one or more second data signals from the second transmitter unit, wherein the communication unit is configured to wirelessly communicate with the second transmitter unit after termination of wireless communication with the first transmitter unit; process the second data signals to produce processed data signals; and provide the processed data signals for display.
    Type: Application
    Filed: May 23, 2022
    Publication date: September 1, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventor: Benjamin Jay Feldman
  • Publication number: 20220273203
    Abstract: Methods and apparatus for acquiring data associated with a monitored analyte level, determining a glucose level based at least in part on the acquired data associated with the monitored analyte level, manipulating a data set based on a processing mode following the glucose level determination, where the processing mode includes one of a data set transmission and output display, a data set storing and output display without transmission, or a data set transmission and data set storing without output display are provided.
    Type: Application
    Filed: February 24, 2022
    Publication date: September 1, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventor: Gary A. Hayter
  • Patent number: 11424015
    Abstract: Methods, devices, and systems are provided that determine analyte trends according to different methods depending on whether a change-resistant state is active or not active. The method used when the change-resistant state is activated provides for different requirements for a resulting analyte trend to transition between states (e.g., level to non-level). Furthermore, in some aspects, methods, devices, and systems of selecting or modifying a response rate of an analyte monitoring device for an individual user are provided. User instructions for selecting or modifying a response rate of the device or system is received externally via a user interface or communication channel. The response rate of the analyte monitoring device or system is then selected or modified to the first response rate, and the device or system operated with the first response rate.
    Type: Grant
    Filed: October 3, 2018
    Date of Patent: August 23, 2022
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Kenneth J. Doniger, Gary A. Hayter, Scott A. Springer, Geoffrey V. McGarraugh
  • Publication number: 20220260551
    Abstract: Techniques for data processing and control for a glucose monitoring system are provided, including obtaining a first sensitivity of a glucose sensor; obtaining a second sensitivity of the glucose sensor; comparing a difference between the first sensitivity and the second sensitivity to a predetermined range of values; if the difference is outside the predetermined range of the values, causing a calibration routine for the glucose sensor to be performed; and if the difference is within the predetermined range of values determining a composite sensitivity for a current calibration of the glucose sensor based on the first sensitivity and the second sensitivity and calculating the glucose level based on the current calibration of the glucose sensor.
    Type: Application
    Filed: May 3, 2022
    Publication date: August 18, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Gary Alan Hayter, Geoffrey V. McGarraugh, Andrew H. Naegeli, John Charles Mazza, Benjamin Jay Feldman
  • Publication number: 20220263904
    Abstract: Techniques include a medical device including processors, one or more sensors configured to generate signals corresponding to one or more physiological signals detected in a body of a user, a communication module configured to communicate wirelessly with a receiving device using a communication protocol capable of data transmission or reception at multiple data rates, and memories including instructions to cause the one or more processors to transmit information to the receiving device indicating that the communication module is configured to communicate using the multiple data rates; determine one of the data rates to be utilized for at least one of data transmission or reception during a communication session with the receiving device; initialize the communication session with the receiving device using the determined data rate; and transmit, via to the receiving device and using the determined data rate, communications based on the signals corresponding to the physiological signals.
    Type: Application
    Filed: May 4, 2022
    Publication date: August 18, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Xuandong Hua, Jean-Pierre Cole, Perry Li, Souvik Dubey
  • Patent number: 11406293
    Abstract: Methods, devices, and systems may use a kinetic model to determine physiological parameters related to the kinetics of red blood cell glycation, elimination, and generation. Such physiological parameters can be used, for example, to determine a more reliable calculated HbA1c. In another example, a method may comprise: receiving a plurality of glucose levels over a time period; receiving a glycated hemoglobin (HbA1c) level corresponding to an end of the time period; determining at least one physiological parameter selected from the group consisting of: a red blood cell glycation rate constant (kgly), a red blood cell generation rate constant (kgen), a red blood cell elimination constant (kage), and an apparent glycation constant (K), based on (1) the plurality of glucose levels and (2) the HbA1c level; and adjusting a glucose level target based on the at least one physiological parameter.
    Type: Grant
    Filed: February 21, 2018
    Date of Patent: August 9, 2022
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Yongjin Xu, Timothy C. Dunn, Gary Hayter
  • Patent number: 11406331
    Abstract: Methods of determining when to activate an analyte, e.g. glucose, related alarm, such as a hypoglycemia alarm, of a continuous analyte monitor is provided. Also provided are systems, devices and kits.
    Type: Grant
    Filed: March 8, 2018
    Date of Patent: August 9, 2022
    Assignee: Abbott Diabetes Care Inc.
    Inventor: Erwin Satrya Budiman
  • Publication number: 20220240821
    Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.
    Type: Application
    Filed: April 14, 2022
    Publication date: August 4, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Michael Love, Phillip Yee, Gary Alan Hayter, R. Curtis Jennewine, Glenn Howard Berman
  • Patent number: 11399748
    Abstract: An analyte monitor includes a sensor, a sensor control unit, and a display unit. The sensor has, for example, a substrate, a recessed channel formed in the substrate, and conductive material disposed in the recessed channel to form a working electrode. The sensor control unit typically has a housing adapted for placement on skin and is adapted to receive a portion of an electrochemical sensor. The sensor control unit also includes two or more conductive contacts disposed on the housing and configured for coupling to two or more contact pads on the sensor. A transmitter is disposed in the housing and coupled to the plurality of conductive contacts for transmitting data obtained using the sensor. The display unit has a receiver for receiving data transmitted by the transmitter of the sensor control unit and a display coupled to the receiver for displaying an indication of a level of an analyte.
    Type: Grant
    Filed: November 18, 2021
    Date of Patent: August 2, 2022
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Thomas A. Peyser, Adam Heller
  • Publication number: 20220233111
    Abstract: Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.
    Type: Application
    Filed: April 14, 2022
    Publication date: July 28, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Wesley Scott Harper, Annie C. Tan, Timothy Christian Dunn, Mark Kent Sloan, Kenneth J. Doniger, Michael Love, Phillip Yee, Gary Alan Hayter, R. Curtis Jennewine, Glenn Howard Berman
  • Publication number: 20220236252
    Abstract: Techniques for data processing and control for a glucose monitoring system are provided, including obtaining a first sensitivity of a glucose sensor; obtaining a second sensitivity of the glucose sensor; comparing a difference between the first sensitivity and the second sensitivity to a predetermined range of values; if the difference is outside the predetermined range of the values, causing a calibration routine for the glucose sensor to be performed; and if the difference is within the predetermined range of values determining a composite sensitivity for a current calibration of the glucose sensor based on the first sensitivity and the second sensitivity and calculating the glucose level based on the current calibration of the glucose sensor.
    Type: Application
    Filed: April 11, 2022
    Publication date: July 28, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Gary Alan Hayter, Geoffrey V. McGarraugh, Andrew H. Naegeli, John Charles Mazza, Benjamin Jay Feldman
  • Publication number: 20220233116
    Abstract: Systems are provided for an in vivo ketone sensor having a distal portion configured for placement in contact with an interstitial fluid of a user and a proximal portion including a working electrode, a sensing layer with ?-hydroxybutyrate dehydrogenase, and a membrane layer configured to limit transport of one or more biomolecules. The in vivo ketone sensor is configured to generate signals at the working electrode corresponding to an amount of ketone in the interstitial fluid. Further, the systems includes a sensor control unit having at least one contact in electrical communication with the proximal portion of the sensor, which is configured to receive the generated signals, and convert the generated signals to ketone concentration data using a sensitivity associated with the in vivo ketone sensor. Also included is a transmitter configured to communicate ketone concentration data to a remote device.
    Type: Application
    Filed: January 26, 2022
    Publication date: July 28, 2022
    Applicant: ABBOTT DIABETES CARE INC.
    Inventors: Shridhara A. Karinka, Stephen Oja
  • Patent number: D961778
    Type: Grant
    Filed: April 1, 2021
    Date of Patent: August 23, 2022
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: John C. Mazza, Andrew H. Naegeli, Gary Ashley Stafford
  • Patent number: D962446
    Type: Grant
    Filed: April 1, 2021
    Date of Patent: August 30, 2022
    Assignee: ABBOTT DIABETES CARE, INC.
    Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Lei He, Gary Alan Hayter, Namvar Kiaie, Jean-Pierre Cole, Marc Barry Taub